The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Procalcitonin Algorithms for Antibiotic Therapy Decisions: A Systematic Review of Randomized Controlled Trials and Recommendations for Clinical Algorithms
Abstract
Previous randomized controlled trials suggest that using clinical algorithms based on procalcitonin levels, a marker of bacterial infections, results in reduced antibiotic use without a deleterious effect on clinical outcomes. However, algorithms differed among trials and were embedded primarily within the European health care setting. Herein, we summarize the design, efficacy, and safety of previous randomized controlled trials and propose adapted algorithms for US settings. We performed a systematic search and included all 14 randomized controlled trials (N = 4467 patients) that investigated procalcitonin algorithms for antibiotic treatment decisions in adult patients with respiratory tract infections and sepsis from primary care, emergency department (ED), and intensive care unit settings. We found no significant difference in mortality between procalcitonin-treated and control patients overall (odds ratio, 0.91; 95% confidence interval, 0.73-1.14) or in primary care (0.13; 0-6.64), ED (0.95; 0.67-1.36), and intensive care unit (0.89; 0.66-1.20) settings individually. A consistent reduction was observed in antibiotic prescription and/or duration of therapy, mainly owing to lower prescribing rates in low-acuity primary care and ED patients, and shorter duration of therapy in moderate- and high-acuity ED and intensive care unit patients. Measurement of procalcitonin levels for antibiotic decisions in patients with respiratory tract infections and sepsis appears to reduce antibiotic exposure without worsening the mortality rate. We propose specific procalcitonin algorithms for low-, moderate-, and high-acuity patients as a basis for future trials aiming at reducing antibiotic overconsumption.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Assessing Risk of Bias in Included Studies
Higgins, J. P., & Altman, D. G. (2008) · Cochrane Handbook for Systematic Reviews of Interventions · doi:10.1002/9780470712184.ch8 · Cited by 3,396 · cited 1×
“numbered, opaque, sealed envelopes was reported); adequate masking of physicians, patients, and outcome assessors; low risk of attrition bias (ie, minimal loss to follow-up and performance of adequate sensitivity analyses); and freedom from selective outcome reporting (eg, if al l stated outcomes were reported).(13) T…”
BackgroundBeta blockade during and after myocardial infarction: An overview of the randomized trials
Yusuf, S., Peto, R., Lewis, J., Collins, R., & Sleight, P. (1985) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(85)80003-7 · Cited by 3,205 · cited 1×
“We pooled results and calculated odds ratios (ORs) with 95% confidence intervals (CIs) for overall mortality rate using the Peto method.(16) The Peto ORs are appropriate when intervention effects are small (ie, when ORs are close to 1), events are not particularly common, and studies have balanced numbers in intervent…”
MethodInvestigating and dealing with publication and other biases in meta-analysis
Sterne, J. A. C., Egger, M., & Smith, G. D. (2001) · BMJ · doi:10.1136/bmj.323.7304.101 · Cited by 2,225
Simon, L., Gauvin, F., Amre, D. K., Saint-Louis, P., & Lacroix, J. (2004) · Clinical Infectious Diseases · doi:10.1086/421997 · Cited by 1,787
Bouadma, L., Luyt, C.-E., Tubach, F., Cracco, C., Alvarez, A., Schwebel, C., Schortgen, F., Lasocki, S., Veber, B., Dehoux, M., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61879-1 · Cited by 1,183
Christ-Crain, M., Jaccard-Stolz, D., Bingisser, R., Gencay, M. M., Huber, P. R., Tamm, M., & Müller, B. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15591-8 · Cited by 1,096
Schuetz, P., Christ-Crain, M., Thomann, R., Falconnier, C., Wolbers, M., Widmer, I., Neidert, S., Fricker, T., Blum, C., Schild, U., et al. (2009) · JAMA · doi:10.1001/jama.2009.1297 · Cited by 959
Self-citationIncreasing Prevalence of Multidrug-Resistant Streptococcus pneumoniae in the United States
Whitney, C. G., Farley, M. M., Hadler, J., Harrison, L. H., Lexau, C., Reingold, A., Lefkowitz, L., Cieslak, P. R., Cetron, M., Zell, E. R., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012283432603 · Cited by 888
Cited by
Procalcitonin as a diagnostic marker for sepsis: A systematic review and meta-analysis.
Wacker, C., Prkno, A., Brunkhorst, F. M., & Schlattmann, P. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(12)70323-7 · Cited by 1,198
Baran, D. A., Grines, C. L., Bailey, S., Burkhoff, D., Hall, S. A., Henry, T. D., Hollenberg, S. M., Kapur, N. K., O'Neill, W., Ornato, J. P., et al. (2019) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.28329 · Cited by 1,017
Faix, J. D. (2013) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2013.764490 · Cited by 663
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections
Schuetz, P., Wirz, Y., Sager, R., Christ-Crain, M., Stolz, D., Tamm, M., Bouadma, L., Luyt, C. E., Wolff, M., Chastre, J., et al. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007498.pub3 · Cited by 649
Self-citationBetter Tests, Better Care: Improved Diagnostics for Infectious Diseases
Caliendo, A. M., Gilbert, D. N., Ginocchio, C. C., Hanson, K. E., May, L., Quinn, T. C., Tenover, F. C., Alland, D., Blaschke, A. J., Bonomo, R. A., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit578 · Cited by 628
New Approaches to Sepsis: Molecular Diagnostics and Biomarkers
Reinhart, K., Bauer, M., Riedemann, N. C., & Hartog, C. S. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.00016-12 · Cited by 533
Schuetz, P., Wirz, Y., Sager, R., Christ-Crain, M., Stolz, D., Tamm, M., Bouadma, L., Luyt, C. E., Wolff, M., Chastre, J., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30592-3 · Cited by 486
Self-citationSepsis: Multiple Abnormalities, Heterogeneous Responses, and Evolving Understanding
Iskander, K. N., Osuchowski, M. F., Stearns-Kurosawa, D. J., Kurosawa, S., Stepien, D., Valentine, C., & Remick, D. G. (2013) · Physiological Reviews · doi:10.1152/physrev.00037.2012 · Cited by 453
Characteristics and outcomes of culture-negative versus culture-positive severe sepsis.
Phua, J., Ngerng, W. J., See, K. C., Tay, C. K., Kiong, T., Lim, H. F., Chew, M. Y., Yip, H. S., Tan, A., Khalizah, H. J., et al. (2013) · Critical Care · doi:10.1186/cc12896 · Cited by 382
Diagnostic value and prognostic evaluation of Presepsin for sepsis in an emergency department
Liu, B., Chen, Y.-X., Yin, Q., Zhao, Y.-Z., & Li, C.-S. (2013) · Critical Care · doi:10.1186/cc13070 · Cited by 299
Schuetz, P., Birkhahn, R., Sherwin, R., Jones, A. E., Singer, A., Kline, J. A., Runyon, M. S., Self, W. H., Courtney, D. M., Nowak, R. M., et al. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002321 · Cited by 296
Self-citationRyan, R. E., Santesso, N., Lowe, D., Hill, S., Grimshaw, J. M., Prictor, M., Kaufman, C., Cowie, G., & Taylor, M. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007768.pub3 · Cited by 273
Schuetz, P., Briel, M., Christ-Crain, M., Stolz, D., Bouadma, L., Wolff, M., Luyt, C.-E., Chastre, J., Tubach, F., Kristoffersen, K. B., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis464 · Cited by 280
Self-citationProcalcitonin-guided diagnosis and antibiotic stewardship revisited
Sager, R., Kutz, A., Mueller, B., & Schuetz, P. (2017) · BMC Medicine · doi:10.1186/s12916-017-0795-7 · Cited by 280
Self-citationSchuetz, P., Beishuizen, A., Broyles, M., Ferrer, R., Gavazzi, G., Gluck, E. H., González del Castillo, J., Jensen, J.-U., Kanizsai, P. L., Kwa, A. L. H., et al. (2019) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2018-1181 · Cited by 279
Self-citationThe antibiotic course has had its day
Llewelyn, M. J., Fitzpatrick, J. M., Darwin, E., SarahTonkin-Crine, Gorton, C., Paul, J., Peto, T. E. A., Yardley, L., Hopkins, S., & Walker, A. S. (2017) · BMJ · doi:10.1136/bmj.j3418 · Cited by 269
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections
Schuetz, P., Müller, B., Christ-Crain, M., Stolz, D., Tamm, M., Bouadma, L., Luyt, C. E., Wolff, M., Chastre, J., Tubach, F., et al. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007498.pub2 · Cited by 264
Self-citationPrkno, A., Wacker, C., Brunkhorst, F. M., & Schlattmann, P. (2013) · Critical Care · doi:10.1186/cc13157 · Cited by 260
Oliveira, C. F., Botoni, F. A., Oliveira, C. R. A., Silva, C. B., Pereira, H. A., Serufo, J. C., & Nobre, V. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31828e969f · Cited by 213
Bacterial Complications of Respiratory Tract Viral Illness: A Comprehensive Evaluation
Falsey, A. R., Becker, K. L., Swinburne, A. J., Nylen, E. S., Formica, M. A., Hennessey, P. A., Criddle, M. M., Peterson, D. R., Baran, A., & Walsh, E. E. (2013) · Journal of Infectious Diseases · doi:10.1093/infdis/jit190 · Cited by 159
“25 ng/mL are uncommon with invasive bacterial disease, and PCT determinations have been used as a guide to antibiotic therapy in patients with respiratory tract illnesses, including community-acquired pneumonia (CAP) and acute exacerbation of chronic obstructive pulmonary disease (COPD), without an increased frequency…”
MethodDavies, J. (2015) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2014-202807 · Cited by 135
“Guidance on the interpretation of PCT results is largely based on recommendations by Schuetz et al.11 Optimal cut-offs for PCT depend on the clinical situations, which dictates the pretest probability of disease (table 2).”
Method
Metadata
- Authors
- Schuetz, P.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2011-08-08
- Volume
- 171
- Issue
- 15
- Pages
- 1322
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W2162217108
- Cited by
- 386
- References
- 38
- FWCI
- 28.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.